Tatiana Kisseleva received her medical degree at Russian University of Friendship (Moscow, Russia). She finished her graduate studies at Christian-Albrecht University in Germany. As a postdoctoral fellow at Columbia University, she studied signal transduction and transgenic mouse technologies. Currently, she is a Professor at the University of California San Diego. Since joining UC San Diego in 2007, her lab has focused on the characterization of the origin of fibrogenic myofibroblasts and the identification of novel targets for anti-fibrotic therapy.